glp 1 fda compounding GLP-1 is still in limbo. Will the leave it for the next administration? FDA Phasing Out Compounded GLP-1

By blocking sodium-glucose co-transporter-2 in the kidneys, they promote glucose excretion through urine, effectively lowering blood sugar levels

Drugs Under Market Approval Application Currently, there are 8 single-target GLP1R drugs in the market approval application stage

They checked in on the phone or by text and if I had a question and I was in Lafayette and I would stop by the office one of them would come to answer my questions

The goal is maximum consistent therapeutic effect

Across both programs, researchers tracked adverse events meticulously, documenting everything from nausea to injection site reactions